Home
>
Stock Market
>
>
Aarey Drugs And Pharmaceuticals Ltd

Aarey Drugs And Pharmaceuticals Ltd share price and stock overview

Aarey Drugs And Pharmaceuticals Ltd (NSE: AAREYDRUGS, BSE: 524412) operates in the Pharmaceuticals - Indian - Bulk Drugs sector. The stock has an ISIN of INE198H01019 and a face value of Rs 10. As of 29 October 2026, it trades at Rs (109.37) with a market capitalisation of Rs 345.52 crore. Figures are live and subject to change.

Aarey Drugs And Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs

NSE BSE

109.37 1.32 (1.22%) upARrowC

As on: 29-Oct-2026 , 01:37 PM

Market Cap(₹Cr) 345.52

Book Value(₹Cr) 53.2789071

BSE Code : 524412 NSE Symbol : AAREYDRUGS EPS(TTM) : 1.31 ISIN Demat : INE198H01019 P/E(TTM) : 82.75 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

73,912.53

Todday's Low

73,181.90

Open at

73,268.47

Previous Close

73,246.03

Volumes

0.00

Avg Price

611.38

Historical Performance

News

08 Oct 26

Aarey Drugs receives certificate from MUFG Intime for period ending September 30, 2026

Aarey Drugs & Pharmaceuticals Limited informed the BSE Limited and National Stock Exchange of India Limited that it has received a certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026.

23 Sep 26

Aarey Drugs restricts insider trading ahead of September 2026 financial results release

Aarey Drugs and Pharmaceuticals Limited will close its trading window for insiders, designated persons, and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations and circulars issued by the BSE and NSE.

07 Aug 26

AAREY DRUGS to convene board meeting for quarterly results announcement on August 14

AAREY DRUGS & PHARMACEUTICALS LIMITED will hold a board meeting on Friday, August 14, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026, and other matters, according to a filing with the BSE Limited and National Stock Exchange of India Limited.

01 Jun 26

Aarey Drugs & Pharmaceuticals standalone net profit rises 231.91% in the March 2026 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 231.91% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
28-10-26	102.11	109.70	102.11	108.05	140508	1246	15023397.98	22698.85
27-10-26	100.13	106.95	100.13	106.58	156560	1349	16596397.70	22749.75
26-10-26	105.99	105.99	101.40	103.19	235039	1006	24180227.15	22753.20
23-10-26	108.10	110.64	104.89	106.73	292242	1223	31089281.63	22600.00
22-10-26	111.93	114.00	108.01	110.41	208417	1253	23195544.18	22687.65
21-10-26	114.00	114.70	110.00	111.93	237818	1417	26694474.50	22811.35
19-10-26	114.80	114.80	110.00	113.87	199690	2231	22424288.70	22888.95
16-10-26	107.01	113.50	105.21	112.91	187209	2004	20707226.07	23146.15
15-10-26	106.96	108.96	105.00	108.74	141631	1150	15245779.66	22997.35
14-10-26	103.10	106.95	102.00	106.32	209543	1408	22233378.83	22622.70

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

345.52

PE Ratio

82.75

PB Ratio

2.03

Dividend Yield

ROE

2.75

ROCE

5.58

Book Value (₹)

53.2789071

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	2010000	6.31	2010000	1
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	11202443	35.15	11202443	7
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

13212443

41.45

13212443

Total ShareHolding for Promoter & Group

13212443

41.45

13212443

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	0	0.00	0	0
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	1362317	4.27	1362317	4
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	0	0.00	0	0
Mutual Funds / UTI	0	0.00	0	0
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	459667	1.44	459667	1
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

1821984

5.72

1821984

Non Institution

Bodies Corporate	2887894	9.06	2866414	86
Clearing Members	336526	1.06	336526	13
Directors & their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	99338	0.31	99338	79
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	523560	1.64	523560	184
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	8405796	26.37	7405796	100
Individuals holding nominal share capital up to Rs. 1 lakh	4407641	13.83	3919042	13002
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

16839876

52.83

15329797

13472

Total Public Shareholding

18661860

58.55

17151781

13477

Total of Promoter & Public ShareHolding

31874303

100.00

30364224

13485

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

31874303

100.00

30364224

13485

Financials (₹ in cr)

Consolidated Standalone

No Data Available

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	28.45	28.45	28.05	25.38	25.38	23.38
Reserves Total	118.20	107.51	99.79	87.39	85.94	73.16
Equity Share Warrants	0.00	0.00	2.47	2.32	2.32	2.32
Equity Application Money	3.77	2.52	2.47	2.32	0.00	0.00
Total Shareholders Funds	150.42	138.48	132.78	117.41	113.64	98.86
Secured Loans	48.64	33.73	30.22	4.36	3.34	0.00
Unsecured Loans	1.32	1.13	1.13	33.36	10.82	18.02
Total Debt	49.96	34.86	31.35	37.72	14.16	18.02
Other Liabilities	0.00	0.00	0.00	0.00	0.00	1.81
Total Liabilities	200.38	173.34	164.13	155.13	127.80	118.69
APPLICATION OF FUNDS :
Gross Block	43.39	39.10	33.89	33.17	32.13	29.93
Less : Accumulated Depreciation	25.73	22.88	20.93	19.23	17.66	15.67
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	17.66	16.22	12.96	13.94	14.47	14.26
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	8.12	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.12	2.12	1.38	0.40	0.40	0.40
Current Assets, Loans & Advances
Inventories	41.54	45.48	34.68	28.82	13.68	18.46
Sundry Debtors	129.65	133.46	184.48	189.78	136.28	162.01
Cash and Bank Balance	1.40	1.47	1.59	0.71	0.19	0.65
Loans and Advances	90.35	85.19	61.83	51.30	68.66	37.25
Total Current Assets	262.94	265.61	282.58	270.61	218.81	218.38
Less : Current Liabilities and Provisions
Current Liabilities	92.38	112.21	134.35	129.50	110.69	111.13
Provisions	3.71	4.13	4.06	5.27	5.23	1.66
Total Current Liabilities & Provisions	96.09	116.34	138.41	134.78	115.92	112.79
Net Current Assets	166.85	149.27	144.17	135.83	102.90	105.59
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.15	0.00	0.67	0.04	0.11	0.00
Deferred Tax Liability	0.92	0.92	1.42	1.46	1.56	1.56
Net Deferred Tax	-0.77	-0.92	-0.75	-1.42	-1.45	-1.56
Other Assets	6.41	6.65	6.37	6.38	11.49	0.00
Total Assets	200.39	173.34	164.13	155.13	127.81	118.69
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	2.25	1.35	5.58	-4.48	2.20
Investing Activities	-3.21	0.44	-1.70	-5.94	-12.41
Net Cash Flow	-0.46	0.51	0.89	-0.12	-0.07
Operating Activities	0.50	-1.28	-2.99	10.30	10.14

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Drugs Ltd

449.90

(+0.45%)

Acutaas Chemical...

4,011.00

(+8.11%)

Anuh Pharma Ltd

79.96

(+0.44%)

Asston Pharmaceu...

Astonea Labs Ltd

Auro Laboratorie...

Bacil Pharma Ltd

Beta Drugs Ltd

1,916.80

(-3.04%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

MRG

Mihir R Ghatalia

Chairman / Executive Director / Managing Director

Executive

Functional Directors

NRG

Nimit R Ghatalia

E D & Wholetime Director

Dir.

Independent Directors

BRG

BINA RAJESH GHATALIA

Non-Exec & Non-Independent Dir

Ind.

CKM

Chetan K Mehta

Independent Non Exe. Director

Ind.

LRT

Lalit R Tulsiani

Independent Non Exe. Director

Ind.

Anil Mandal

Independent Non Exe. Director

Ind.

Other Officials

KCJ

KAILASH CHAND JETHLIA

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Aarey Drugs And Pharmaceuticals Ltd? −

Aarey Drugs And Pharmaceuticals Ltd trades on NSE under AAREYDRUGS and on BSE under code 524412. The ISIN is INE198H01019 and the face value is Rs 10.

What is the share price of Aarey Drugs And Pharmaceuticals Ltd today? +

As of 29 October 2026, Aarey Drugs And Pharmaceuticals Ltd trades at Rs 109.37, a change of 1.32 (1.22%) on the day. Prices are live and subject to change.

What is the market capitalisation of Aarey Drugs And Pharmaceuticals Ltd? +

As of 29 October 2026, Aarey Drugs And Pharmaceuticals Ltd has a market cap of about Rs 345.52 crore. This figure is live and moves with the share price.

Is Aarey Drugs And Pharmaceuticals Ltd profitable? +

In , Aarey Drugs And Pharmaceuticals Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Aarey Drugs And Pharmaceuticals Ltd? +

: As of 29 October 2026, the PE (TTM) for Aarey Drugs And Pharmaceuticals Ltd is 82.75 and the price-to-book ratio is 2.03. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Aarey Drugs And Pharmaceuticals Ltd pay a dividend? +

As of 29 October 2026, the dividend yield for Aarey Drugs And Pharmaceuticals Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Aarey Drugs And Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 41.45% of Aarey Drugs And Pharmaceuticals Ltd. Public shareholding is 58.55%, including mutual funds at 0.00% and foreign institutional investors at 4.27%.

What were the latest annual financials of Aarey Drugs And Pharmaceuticals Ltd? +

In , Aarey Drugs And Pharmaceuticals Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .